<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03400098</url>
  </required_header>
  <id_info>
    <org_study_id>ISIS 420915-CS5</org_study_id>
    <nct_id>NCT03400098</nct_id>
  </id_info>
  <brief_title>ATTR Expanded Access Program (EAP) by Ionis</brief_title>
  <official_title>Expanded Access Program for Inotersen (ISIS 420915) in Patients With Hereditary Transthyretin Amyloidosis (hATTR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ionis Pharmaceuticals, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Clinigen Group PLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ionis Pharmaceuticals, Inc.</source>
  <brief_summary>
    <textblock>
      The purpose of this program is to provide expanded access to Inotersen for up to 100 Patients
      with Hereditary Transthyretin Amyloidosis (hTTR).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Program is intended to provided expanded access to Inotersen for eligible patients with
      hATTR who have limited or no available treatment options.
    </textblock>
  </detailed_description>
  <overall_status>Available</overall_status>
  <study_type>Expanded Access</study_type>
  <expanded_access_info>
    <expanded_access_type_treatment>Yes</expanded_access_type_treatment>
  </expanded_access_info>
  <condition>Amyloidosis, Hereditary</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Inotersen</intervention_name>
    <description>Inotersen administered by subcutaneous (SC) injections in the abdomen, thigh, or upper arm</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female at least 18 years of age with a diagnosis of hATTR

          -  Symptoms consistent with polyneuropathy

          -  Meet Polyneuropathy Disability (PND) Stage I-III requirements

        Exclusion Criteria:

          -  Known Primary Amyloidosis, Leptomeningeal Amyloidosis or Monoclonal Gammopathy of
             Undetermined Significance or Multiple Myeloma

          -  Have inadequate cardiac function

          -  Have low platelet counts

          -  Have inadequate renal function
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Eugene Schneider, MD</last_name>
    <role>Study Director</role>
    <affiliation>Vice President, Clinical Development, Ionis</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>VP, Clinical Development</last_name>
    <phone>1-833-288-7327</phone>
    <email>ATTREAP@ionisph.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mayo Clinic Cancer Center</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85255</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California - Irvine</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92697</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Veena Mathew</last_name>
      <email>vmathew@uci.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cedars-Sinai</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SC3 Research - Pasadena</name>
      <address>
        <city>Pasadena</city>
        <state>California</state>
        <zip>91105</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Richard A Shubin, MD</last_name>
      <phone>626-250-2070</phone>
      <email>shubinpi@neurosearch-usa.com</email>
    </contact>
    <contact_backup>
      <last_name>Brakail Franklin</last_name>
      <phone>626-765-9362</phone>
      <email>brakail.franklin@neurosearch-usa.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of California - San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Cancer Center</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32224</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Taimur Sher, MD</last_name>
      <phone>904-953-2607</phone>
      <email>sher.taimur@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Andrew M Hendrix</last_name>
      <phone>904-953-2606</phone>
      <email>hendrix.andrew@mayo.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cancer Specialists of North Florida</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <phone>904-538-4488</phone>
      <email>research@csnf.us</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Evanston</city>
        <state>Illinois</state>
        <zip>60208</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Senda Ajroud-Driss, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Benjamin Joslin</last_name>
      <phone>312-503-7504</phone>
      <email>ben.joslin@northwestern.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Indiana University School of Medicine</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Janna Hilligoss</last_name>
      <email>jhilligo@iupui.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johns Hopkins University School of Medicine</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Michael Polydefkis, MD MHS</last_name>
      <phone>410-502-2909</phone>
      <email>mpolyde@jhmi.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kathy Burks, CRNP</last_name>
      <email>kburks1@jhmi.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Boston University Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02118</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>John L Berk, MD</last_name>
      <phone>617-353-4365</phone>
      <email>jberk@bu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tennyson B Huny</last_name>
      <phone>617-638-4903</phone>
      <email>tbhunt@bu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Mayo Clinic Cancer Center</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55902</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63130</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Daniel Lenihan, MD</last_name>
      <phone>314-362-1291</phone>
      <email>djlenihan@wustl.edu</email>
    </contact>
    <contact_backup>
      <last_name>Caroline Foster</last_name>
      <phone>314-273-6082</phone>
      <email>caroline.foster@wustl.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Neurological Institute at Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Thomas H Brannagan, MD</last_name>
      <phone>212-305-6035</phone>
      <email>tb2325@cumc.columbia.edu</email>
    </contact>
    <contact_backup>
      <last_name>Allan Paras</last_name>
      <phone>212-305-6035</phone>
      <email>ap3476@cumc.columbia.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of North Carolina - Chapel Hill, Department of Neurology</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Rebecca Traub, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Manisha Chopra</last_name>
      <phone>919-843-7857</phone>
      <email>chopram@neurology.unc.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Mazen Hanna, MD</last_name>
      <phone>216-444-3490</phone>
      <email>hannam@ccf.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University, Knight Cardiovascular Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Chafic Karam, MD</last_name>
      <phone>503-494-6865</phone>
      <email>karam@ohsu.edu</email>
    </contact>
    <contact_backup>
      <last_name>Diana Dimitrova</last_name>
      <phone>503-494-9760</phone>
      <email>dimitrov@ohsu.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Penn Presbyterian Medical Center - University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Physicians, Department of Neurology</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MD Anderson</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah - Huntsman Cancer Institute</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84103</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Jose Nativi-Nicolau, MD</last_name>
      <phone>801-587-4659</phone>
      <email>amyloidosis@hci.utah.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jared Cowley</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Virginia Commonwealth University</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23284</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Keyur Shah, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Laura Cei</last_name>
      <phone>804-828-2690</phone>
      <email>laura.cei@vcuhealth.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 8, 2018</study_first_submitted>
  <study_first_submitted_qc>January 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amyloidosis</mesh_term>
    <mesh_term>Amyloidosis, Familial</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

